Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Review Article

A Comprehensive Review on DNA Gyrase Inhibitors

Author(s): S.R. Chitra*, N. Ramalakshmi, Subramani Arunkumar and P. Manimegalai

Volume 20, Issue 6, 2020

Page: [765 - 777] Pages: 13

DOI: 10.2174/1871526520666200102110235

Price: $65

conference banner
Abstract

The newly emerging infectious organisms, the global crisis in antibiotic resistance, and the threat of bioterrorism create an urgent need to discover novel antimicrobial agents. In order to develop novel antimicrobial agents, the mechanism of infectious disease must be better understood. DNA Gyrase is a bacterial enzyme that plays an important role in the replication of DNA and transcription process. It is not present in higher eukaryotes making it a perfect target for developing new antibacterial agents. This review describes the role of DNA gyrase inhibitors in preventing various diseases. In this review, we outline the synthesis and pharmacological action of various novel DNA gyrase inhibitors. DNA gyrase inhibitors were used to treat tuberculosis, bacterial, fungal infections and malaria. DNA gyrase inhibitors mainly act by preventing the supercoiling of DNA strands.

Keywords: DNA gyrase inhibitors, docking, antibacterial, anticancer, antimalarial, fungal infections.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy